A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients

Acta Psychiatrica Scandinavica

Volumn 93, Issue 3, 1996, Pages 184-190

  Hoyberg O J ^a   Maragakis, B ^b   Mullin, J ^c   Norum, D ^d   Stordall, E ^e   Ekdahl, P ^f   Ose, E ^g   Moksnes, K M ^h   Sennef, C ⁱ  

^a Fylkes Hospital I Molde   (Norway)

^b Billinge Hospital   (United Kingdom)

^c De la Pole Hospital   (United Kingdom)

^d Ostfold Central Hospital   (Norway)

^e Namdal Hospital   (Norway)

^f Sandviken Hospital ^*  (Norway)

^g Department of Psychiatry   (Norway)

^h Dikemark Hospital   (Norway)

ⁱ NV ORGANON   (Netherlands)

Author keywords

amitriptyline; elderly; major depression; mirtazapine

Indexed keywords

AMITRIPTYLINE; MIRTAZAPINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DROWSINESS; FATIGUE; FEMALE; GERONTOPSYCHIATRY; HEADACHE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; TACHYCARDIA; TREMOR; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0029994575     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1996.tb10629.x     Document Type: Article

References (39)

1. MENDELS J. Clinical management of the depressed geriatric patient: current therapeutic options. Am J Med 1993: 94: Suppl. 5: 13-18.
2. NIH Consensus Development Panel on Depression in Late Life. Diagnosis and treatment of depression in late life. JAMA 1992: 268: 1018-1024.
3. BLAZER, D. Depression in the elderly. N Engl J Med 1989: 320: 164-166.
4. PHILPOTT RM. Affective disorder and physical illness in old age. Int Clin Psychopharmacol 1990: 5: Suppl: 7-20.
5. ROVNER BW. Depression and increased risk of mortality in the nursing home patients. Am J Med 1993: 94 Suppl: 5A: 19-22.
6. KATONA C. Depression in old age. Rev Clin Gerontol 1991: 1: 371-384.
7. PÉREZ-STABLE TJ, MIRANDA J, MUNOZ RF, YING YW. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990: 150: 1083-1088.
8. Diagnosis and treatment of depression in late life: the NIH consensus development conference statement. Psychopharmacol Bull 1993: 29: 87-100.
9. REYNOLDS CF. Treatment of depression in special populations. J Clin Psychiatry 1992: 53: Suppl 9: 45-53.
10. REYNOLDS CF, LEBOWITZ BD, SCHNEIDER LS. The NIH consensus development conference on the diagnosis and treatment of depression in late life: an overview. Psychopharmacol Bull 1993: 29: 83-85.
11. PEABODY CA, WHITEFORD HA, HOLLISTER LE. Anti-depressants and the elderly. J Am Geriatr Soc 1986: 34: 869-874.
12. BALDESSARINI RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 1989: 50: 117-126.
13. FEIGNER JP, COHN JB. Double-blind, comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. J Clin Psychiatry 1985: 46: 20-25.
14. BRYMER C, HUNTER B, WINOGRAD C. Fluoxetine in elderly patients: is there cause for concern? J Am Ger Soc 1992: 40: 902-905.
15. HAIDER A, MILLER DR, STATON RD. Use of serotonergic drugs for treating depression in older patients. Geriatrics 1993: 48: 48-51.
16. LEINONEN E, KOPONEN H, LEPOLA U. Delirium during fluoxetine treatment: a case report. Ann Clin Psychiatry 1993: 5: 255-258.
17. PRESKORN SH. Recent psychopharmacologic advances in antidepressant therapy for the elderly. Am J Med 1993: 94: Suppl 5: 5-12.
18. DE BOER TH, MAURA G, RAITERI M. Neurochemical and autonomie pharmacological properties of the 6-aza-analogue of mianserin. Org 3770 and its enantiomers. Neuropsychopharmacol 1988: 27: 399-408.
19. a-mediated serotonergic neurotransmission. CNS Drugs 1995: 41 (Suppl. 1): 29-38.
20. CLEMENT HH, GEMSA D, WESEMAN W. The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studied by in vitro voltametry. Eur J Pharmacol 1992: 217: 43-48.
21. 2-adreno-receptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 1994: 253: R5-R6.
22. NICKOLSON VJ, RADHAKISHUN F, SITSEN JMA, VAN DELFT AML. Remeron (Org 3770), an "atypical" antidepressant with "typical" efficacy. Abstract presented at the 9th World Congress of Psychiatry, Rio de Janeiro: June 6th 12th, 1993.
23. CLAGHORN JL. A double-blind, placebo controlled study of Org 3770 in depressed outpatients. J Affect Dis 1995: 34: 167-171.
24. SMITH WT, GLAUDIN V, PANAGIDES J et al. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive episode. Psychopharmacol Bull 1990: 26: 191-6.
25. VAN MOFFAERT M, DE WILDE D, VEREECKEN A et al. Mirtazapine is more effective than trazodone. A controlled study in hospitalized patients with major depression. Int Clin Psychopharmacol 1995: 10: 39.
26. ZIVKOV M, DE JONGH GD. Org 3770 vs. amitriptyline: a 6-week randomised double-blind multicentre trial in hospitalised depressed patients. Hum Psychopharmacol 1995: 10: 173-180.
27. RICHOU H, RUIMY P, CHARBAUT J et al. A multicentre, double-blind, clomipramine-controlled efficacy and safety study of Org 3770. Hum Psychopharmacol 1995: 10: 263-271.
28. MARTTILA M, JÄÄSKELÄINEN J, JARVI R et al. A double-blind study comparing the efficacy and tolerability of Org 3770 and doxepin in patients with major depression. Eur Neuropsychopharmacol (in press).
29. SITSEN AMJ, ZIVKOV M. Mirtazapine: clinical profile. CNS Drugs 1995: 41 (Suppl. 1): 39-48.
30. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edn. Washington, DC: American Psychiatric Association, 1980.
31. HAMILTON M. Development of a rating scale for a primary depression. Br J Soc Clin Psychol 1967: 6: 278-296.
32. REISBERG B. The Brief Cognitive Rating Scale and Global Deterioration Scale. In: COOK T, FERRIS S, BARTUS R, ed. Assessment in geriatric psychopharmacology. New Canaan, Connecticut: Mark=Powley, 1983: 59-68.
33. MONTGOMERY SA, ÅSBERG M. A new depression rating scale designed to be sensitive to change. Br J Psychiatry 1979: 134: 382-389.
34. GUY W. The ECDEU assessment manual for psychopharmacology, revised. DHEW Publ. No. (ADM) 76-338: Rockville, MD: National Institute of Mental Health, 1976.
35. COHN CK, SHRIVASTAVA R, MENDELS J et al. Double-blind multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990: 51: (12, Suppl. B): 28-33.
36. ALTAMURA A, MAURI MC, COLACURCIO F et al. Trazodone in late life depressive states: a double blind multicenter study versus amitriptyline and mianserin. Psychopharmacol 1988: 95: 34-36.
37. LINGJAERDE O, AHLFORS UG, BECH P, DENKER SJ, ELGEN K. The UKU side effect rating scale. Acta Psychiatr Scand 1987: 76(Suppl. 334): 1-100.
38. DANA-HAERI J, WARRINGTON SJ. Cardiovascular effects of tricyclic antidepressants on elderly people. In: GHOSE K, ed. Antidepressants for elderly people. London: Chapman and Hall, 1989: 163-180.
39. GHOSE K. Side-effects of tricyclic and related antidepressants. In: GHOSE K, ed. Antidepressants for elderly people. London: Chapman and Hall. 1989: 181-200.